Linda Spahiu

Linda Spahiu is an experienced investment manager currently with Karolinska Development since October 2021, focusing on medical innovation and company growth. In addition to this role, Linda serves as a board member for Henlez and PharmNovo, the latter as deputy, and previously held the position of CEO at VOC Diagnostics, leading advancements in cancer diagnostics. Linda's background includes significant consulting and analytic experience at the Boston Consulting Group in the Health Care Practice Area, as well as founding Biomera for healthcare market analysis. Educationally, Linda holds a Master of Science in Biotechnology from KTH Royal Institute of Technology and has a PhD in Biochemical Toxicology, further enhancing expertise in the MedTech and healthcare sectors.